Pacific Biosciences of California, Inc. (BMV:PACB)
27.99
+2.41 (9.42%)
At close: Oct 9, 2025
BMV:PACB Revenue
Pacific Biosciences of California had revenue of $39.77M USD in the quarter ending June 30, 2025, with 10.42% growth. This brings the company's revenue in the last twelve months to $156.11M, down -17.35% year-over-year. In the year 2024, Pacific Biosciences of California had annual revenue of $154.01M, down -23.19%.
Revenue (ttm)
$156.11M
Revenue Growth
-17.35%
P/S Ratio
4.43
Revenue / Employee
$271.50K
Employees
575
Market Cap
13.05B MXN
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 154.01M | -46.51M | -23.19% |
| Dec 31, 2023 | 200.52M | 72.22M | 56.29% |
| Dec 31, 2022 | 128.30M | -2.21M | -1.69% |
| Dec 31, 2021 | 130.51M | 51.62M | 65.43% |
| Dec 31, 2020 | 78.89M | -12.00M | -13.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wal-Mart de México | 1.00T |
| Arca Continental | 250.90B |
| Industrias Peñoles | 142.01B |
| Grupo Financiero Banorte | 134.12B |
| Grupo Elektra | 114.48B |
| GMéxico Transportes | 62.95B |
| Becle | 44.91B |
| Fibra UNO | 30.53B |